Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/603367 stock hub

SHA/603367 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/603367is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.1B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/603367

In the news

Latest news · SHA/603367

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E17.4

P25 23.5P50 41.3P75 83.2

ROE6.6

P25 -0.9P50 4.1P75 8.8

ROIC7.2

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/603367 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

229

Groups with data

Currency

CNY

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	3,114
Employees Change	-188%
Employees Change Percent	-5.69
Enterprise value	CNY 4B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100002VG4
Last refreshed	2026-05-10
Market cap	CNY 7.1B
Price	CNY 15.67
Price currency	CNY
Rev Per Employee	1,083,771.39x
Sector	Healthcare
Sic	2834
Symbol	sha/603367
Website	https://www.cisen-pharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.76%
EV Earnings	9.73x
EV/EBIT	15.59x
EV/EBITDA	8.91x
EV/FCF	7.38x
EV/Sales	1.18x
FCF yield	7.59%
P/B ratio	1.12x
P/E ratio	17.4x
P/S ratio	2.1x
PE Ratio10 Y	15.97x
PE Ratio3 Y	14.46x
PE Ratio5 Y	14.96x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.55%
EBITDA Margin	13.15%
FCF margin	15.95%
Gross margin	49.02%
Gross Profit	CNY 1.7B
Gross Profit Growth	-17.43%
Gross Profit Growth Q	-10.28%
Gross Profit Growth3 Y	-12.57%
Gross Profit Growth5 Y	-4.67%
Net Income	CNY 408.5M
Net Income Growth	-16.57%
Net Income Growth Q	-8.92%
Net Income Growth Years	0%
Net Income Growth3 Y	-0.05%
Net Income Growth5 Y	-1.54%
Pretax Margin	14.22%
Profit Margin	12.1%
Profit Per Employee	CNY 131,166
Profitable Years	15
ROA	2.09
Roa5y	3.15
ROCE	3.93
ROE	6.61
Roe5y	7.74
ROIC	7.23
Roic5y	10.88

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	19.81%
Cagr3y	1.57%
Cagr5y	6.66%
Div CAGR3	10.79%
Div CAGR5	8.77%
EPS Growth	-16.59
EPS Growth Q	-9.38
EPS Growth Years	0
EPS Growth3 Y	-0.02
EPS Growth5 Y	-1.68
FCF Growth	82.1%
FCF Growth Q	316.06%
FCF Growth3 Y	22.26%
FCF Growth5 Y	24.81%
OCF Growth	56.89%
OCF Growth Q	234.77%
OCF Growth10 Y	22.93%
OCF Growth3 Y	24.77%
OCF Growth5 Y	9.91%
Revenue Growth	-10.07x
Revenue Growth Q	-7.59x
Revenue Growth Years	0x
Revenue Growth3 Y	-7.98x
Revenue Growth5 Y	-1.96x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.44
Assets	CNY 7.7B
Cash	CNY 3.2B
Current Assets	CNY 5.4B
Current Liabilities	CNY 1.2B
Debt	CNY 42M
Debt EBITDA	CNY 0.09
Debt Equity	CNY 0.01
Debt FCF	CNY 0.08
Equity	CNY 6.4B
Interest Coverage	190.9
Liabilities	CNY 1.3B
Long Term Assets	CNY 2.2B
Long Term Liabilities	CNY 128.9M
Net Cash	CNY 3.2B
Net Cash By Market Cap	CNY 44.56
Net Cash Growth	15.78%
Net Debt EBITDA	CNY -7.12
Net Debt Equity	CNY -0.5
Net Debt FCF	CNY -5.87
Tangible Book Value	CNY 6.1B
Tangible Book Value Per Share	CNY 13.59
WACC	5.39

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.65
Inventory Turnover	2.48
Net Working Capital	CNY 1.1B
Quick ratio	3.59
Working Capital	CNY 4.3B
Working Capital Turnover	CNY 0.87

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.02%
Dividend Growth	-37.8%
Dividend Growth Years	0%
Dividend per share	CNY 0.32
Dividend Years	8
Dividend Yield	2.04%
Last Dividend	CNY 0.19
Payout Frequency	Semi-Annual
Payout Ratio	44.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	19.79%
200-day SMA	20.05
3Y total return	4.78%
50-day SMA	16.39
50-day SMA vs 200-day SMA	50under200
5Y total return	38.03%
All Time High	35.2
All Time High Change	-55.48%
All Time High Date	2025-08-11
All Time Low	10.3
All Time Low Change	52.14%
All Time Low Date	2022-04-27
ATR	0.41
Beta	0.21
Beta1y	-0.1
Beta2y	0.29
Ch YTD	-9.53
High	15.75
High52	35.2
High52 Date	2025-08-11
High52ch	-55.48%
Low	15.58
Low52	13.35
Low52 Date	2025-05-14
Low52ch	17.55%
Ma50ch	-4.39%
Price vs 200-day SMA	-21.86%
RSI	44.62
RSI Monthly	47.49
RSI Weekly	39.09
Sharpe ratio	0.46x
Sortino ratio	0.86
Total Return	2.02%
Tr YTD	-9.53
Tr1m	-4.1%
Tr1w	-0.19%
Tr3m	-10.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 254.9M
Operating Income Growth	-40.74
Operating Income Growth Q	-1.43
Operating Income Growth3 Y	-10.14
Operating Income Growth5 Y	-5.14
Operating margin	7.55

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	205,658,729%
Net Borrowing	12,204,242
Shares Insiders	6.5%
Shares Institutions	6.41%
Shares Out	452,754,129
Shares Qo Q	0.75%
Shares Yo Y	0.02%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 538.2M
Average Volume	8,765,611.45x
Bv Per Share	14.02
CAPEX	CNY -63.2M
Ch1m	-4.1
Ch1w	-0.19
Ch1y	16.85
Ch3m	-10.2
Ch3y	-4.51
Ch5y	20.17
Ch6m	-23.11
Change	-0.06%
Change From Open	-0.06
Close	15.68
Days Gap	0
Depreciation Amortization	188,959,711
Dollar Volume	70,922,529.7
Earnings Date	2026-08-25
EBIT	CNY 254.9M
EBITDA	CNY 443.9M
EPS	CNY 0.9
F Score	5
FCF	CNY 538.2M
FCF EV Yield	13.54x
FCF Per Share	CNY 1.19
Financing CF	-172,977,995
Fiscal Year End	December
Founded	1,970
Graham Number	16.85669
Graham Upside	7.57
Income Tax	CNY 66.9M
Investing CF	-372,808,577
Is Primary Listing	1
Last Earnings Date	2026-04-03
Last Report Date	2026-03-31
Lynch Fair Value	CNY 4.5
Lynch Upside	-71.26
Ma150	18.33
Ma150ch	-14.49%
Ma20	15.83
Ma20ch	-0.99%
Net CF	53,441,579
Next Earnings Date	2026-08-25
Open	15.68
P FCF Ratio	13.18
P OCF Ratio	11.8
Payment Date	2025-10-13
Position In Range	52.94
Ppne	1,627,117,150
Price Date	2026-05-08
Price EBITDA	CNY 15.98
Ptbv Ratio	1.16
Relative Volume	0.5x
Revenue	3,374,864,107x
Tax By Revenue	1.98x
Tax Rate	13.94%
Tr6m	-23.11%
Volume	4,526,007

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/603367 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.0%

$0.32 annual per share

Payout ratio

+44.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+8.8%

0 consecutive years of growth

Total shareholder yield

+2.0%

Dividend yield + buyback yield combined

Performance

SHA/603367 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/603367?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.4%

Share of float held by funds and institutions

Insider ownership

+6.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

SHA/603367 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.6

Neutral momentum band

Price vs 200-day MA

-21.9%

50/200-day relationship not available

Beta (5Y)

0.21

Less volatile than the market

Sharpe ratio

0.46

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/603367

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/603367 stock rating?

sha/603367 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/603367 analysis?

The full report lives at /stocks/sha/603367/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/603367?

The latest report frames sha/603367 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/603367 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.